Incidence of hepatocellular carcinoma reduced in chronic hepatitis B patients treated with entercavir plus Biejia-Ruangan: extended follow-up of a multicenter, randomised, double-blinded, placebo-controlled trial

Authors
Category Primary study
JournalJournal of hepatology
Year 2022
This article has no abstract
Epistemonikos ID: 1ceb4f182302004185c7f45cc7882374eff5274c
First added on: Feb 01, 2023